Hainan Huluwa Pharmaceutical Group Co. Ltd.SSE: 605199

Semi-annual Performance Forecast for 2026

· Issued by Hainan Huluwa Pharmaceutical Group Co. Ltd. via Shanghai Stock Exchange

Filed with SSE · · 2 pages · Chinese

Summary by 6ix AI

The company anticipates a net profit attributable to shareholders in the range of negative values, reflecting a significant decline compared to the previous year. The forecast highlights challenges such as a marketing transformation and increased fixed costs contributing to the anticipated losses. This preliminary forecast has not been audited by external accountants and is subject to change based on actual performance.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

Hainan Huluwa Pharmaceutical Group Co. Ltd. on 6ix

Earlier from Hainan Huluwa Pharmaceutical

Later from Hainan Huluwa Pharmaceutical

All Hainan Huluwa Pharmaceutical news releases